BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16099079)

  • 1. Costs of running a universal adolescent hepatitis B vaccination programme.
    Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
    Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
    Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
    Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hepatitis B vaccination program targeting adolescents.
    Cassidy WM; Mahoney FJ
    J Adolesc Health; 1995 Oct; 17(4):244-7. PubMed ID: 8580125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study.
    Bramley JC; Wallace LA; Ahmed S; Duff R; Carman WF; Cameron SO; Kitchin NR; Watson MW; Goldberg DJ
    Commun Dis Public Health; 2002 Dec; 5(4):318-20. PubMed ID: 12564249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of state policies on vaccine coverage by age 13 in an insured population.
    Olshen E; Mahon BE; Wang S; Woods ER
    J Adolesc Health; 2007 May; 40(5):405-11. PubMed ID: 17448397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. School-based adolescent hepatitis B vaccination.
    Cassidy WM
    J La State Med Soc; 1999 Dec; 151(12):622-6. PubMed ID: 10643204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences in infant immunization against hepatitis B: did intervention work?
    Takayama JI; Iser JP; Gandelman A
    Prev Med; 1999 Feb; 28(2):160-6. PubMed ID: 10048107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Child and adolescent hepatitis B vaccination--responsibilities of the public health service].
    Nassauer KA
    Gesundheitswesen; 1996 Nov; 58(11):616-7. PubMed ID: 9081503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
    Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; RodrĂ­guez G; GalĂ­ N; Prat A
    Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of universal adolescent hepatitis B vaccine uptake.
    Wallace LA; Bramley JC; Ahmed S; Duff R; Hutchinson SJ; Carman WF; Kitchin NR; Goldberg DJ
    Arch Dis Child; 2004 Nov; 89(11):1041-2. PubMed ID: 15499061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia.
    Levin CE; Nelson CM; Widjaya A; Moniaga V; Anwar C
    Bull World Health Organ; 2005 Jun; 83(6):456-61. PubMed ID: 15976897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated interviewing for hepatitis B risk assessment and vaccination referral.
    Havel RD; Wright MP
    Am J Prev Med; 1997; 13(5):392-5. PubMed ID: 9315273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adolescent hepatitis B immunisation program. The Preston experience.
    Howsam R; Dunn A
    Aust Fam Physician; 1996 Mar; 25(3):352-4. PubMed ID: 8867186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
    Rein DB; Weinbaum CM
    Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.